Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval

BACKGROUND: Obtaining prior authorization (PA) approval for the new direct-acting antiviral (DAA) hepatitis C medications is time consuming and requires specific expertise. Our primary care-based program treats hepatitis C virus (HCV)-infected patients at an urban academic medical center and employs...

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Trang M., Toribio, Wilma, Riazi, Farah, Ciprian, Genesis, Gibbs, Nathalia, Giardina, Martha, Camacho, Jocelyn A., Parrella, Korin, Cambe, Joy, Amory, Catherine, Chasan, Rachel, Sigel, Keith M., Weiss, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862767/
https://www.ncbi.nlm.nih.gov/pubmed/29578854
http://dx.doi.org/10.18553/jmcp.2018.24.4.329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862767/
https://www.ncbi.nlm.nih.gov/pubmed/29578854
http://dx.doi.org/10.18553/jmcp.2018.24.4.329

Ejemplares similares